Associations of genetic polymorphisms of SAA1 with cerebral infarction

10Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Serum amyloid A protein (SAA) is both an inflammatory factor and an apolipoprotein. However, the relation between genetic polymorphisms of SAA and cerebral infarction (CI) remains unclear. Methods and results. The previously reported 4 Single Nucleotide Polymorphisms (rs12218, rs4638289, rs7131332, and rs11603089) of SAA1 gene were genotyped by TaqMan method in a case-control study including 287 cerebral infarction patients and 376 control subjects. We found rs12218 CC genotype and rs7131332 AA genotype were more frequent among CI patients than among controls (9.76% versus 3.19%, P = 0.001; 32.75% versus 24.20%; p = 0.017; respectively). After adjustment of confounding factors such as sex, age, smoking, drinking, hypertension, diabetes, and lipids profile, the difference remained significant in rs12218 (P < 0.01, OR = 2.106, 95% CI: 1.811-7.121). Conclusion: Genetic polymorphism of SAA1 may be a genetic maker of cerebral infarction in Chinese. © 2013 Zhang et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Zhang, L. J., Yuan, B., Li, H. H., Tao, S. B., Yan, H. Q., Chang, L., & Zhao, J. H. (2013). Associations of genetic polymorphisms of SAA1 with cerebral infarction. Lipids in Health and Disease, 12(1). https://doi.org/10.1186/1476-511X-12-130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free